U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C22H25NO2S
Molecular Weight 367.504
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BF-1

SMILES

CCOC1=CC2=C(C=C1)C(=C3CCN(C)CC3)C4=C(OC)C=CC=C4S2

InChI

InChIKey=ANZVBVKYXOGOQC-UHFFFAOYSA-N
InChI=1S/C22H25NO2S/c1-4-25-16-8-9-17-20(14-16)26-19-7-5-6-18(24-3)22(19)21(17)15-10-12-23(2)13-11-15/h5-9,14H,4,10-13H2,1-3H3

HIDE SMILES / InChI

Molecular Formula C22H25NO2S
Molecular Weight 367.504
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
BF-1--a novel selective 5-HT2B receptor antagonist blocking neurogenic dural plasma protein extravasation in guinea pigs.
2015-03-15
Patents
Substance Class Chemical
Created
by admin
on Wed Apr 02 13:37:51 GMT 2025
Edited
by admin
on Wed Apr 02 13:37:51 GMT 2025
Record UNII
366ZW99DGL
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PIPERIDINE, 4-(6-ETHOXY-1-METHOXY-9H-THIOXANTHEN-9-YLIDENE)-1-METHYL-
Preferred Name English
BF-1
Code English
Code System Code Type Description
EPA CompTox
DTXSID70437783
Created by admin on Wed Apr 02 13:37:51 GMT 2025 , Edited by admin on Wed Apr 02 13:37:51 GMT 2025
PRIMARY
FDA UNII
366ZW99DGL
Created by admin on Wed Apr 02 13:37:51 GMT 2025 , Edited by admin on Wed Apr 02 13:37:51 GMT 2025
PRIMARY
CAS
518980-66-0
Created by admin on Wed Apr 02 13:37:51 GMT 2025 , Edited by admin on Wed Apr 02 13:37:51 GMT 2025
PRIMARY
PUBCHEM
10287037
Created by admin on Wed Apr 02 13:37:51 GMT 2025 , Edited by admin on Wed Apr 02 13:37:51 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Ki
Related Record Type Details
ACTIVE MOIETY
Tested for migraine